<VariationArchive RecordType="classified" VariationID="2424699" VariationName="NC_000002.11:g.(?_71900503)_(71913622_?)del" VariationType="Deletion" Accession="VCV002424699" Version="3" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-11-11" DateCreated="2023-02-13" MostRecentSubmission="2023-11-11">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1949778" VariationID="2424699">
      <GeneList>
        <Gene Symbol="DYSF" FullName="dysferlin" GeneID="8291" HGNC_ID="HGNC:3097" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>2p13.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="71453561" stop="71686763" display_start="71453561" display_stop="71686763" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="71680752" stop="71913892" display_start="71680752" display_stop="71913892" Strand="+" />
          </Location>
          <OMIM>603009</OMIM>
        </Gene>
      </GeneList>
      <Name>NC_000002.11:g.(?_71900503)_(71913622_?)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>2p13.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" forDisplay="true" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" innerStart="71900503" innerStop="71913622" display_start="71900503" display_stop="71913622" variantLength="13120" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.11" sequenceAccession="NC_000002" sequenceVersion="11" change="g.(?_71900503)_(71913622_?)del" Assembly="GRCh37">
            <Expression>NC_000002.11:g.(?_71900503)_(71913622_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000002.11:g.(?_71900503)_(71913622_?)del AND Qualitative or quantitative defects of dysferlin" Accession="RCV003113281" Version="2">
        <ClassifiedConditionList TraitSetID="9586">
          <ClassifiedCondition DB="MedGen" ID="C2931687">Qualitative or quantitative defects of dysferlin</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-06-14" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-06-14" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2023-02-13" MostRecentSubmission="2023-11-11">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">19594366</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="9586" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="9484" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Dysferlinopathy</ElementValue>
                <XRef ID="Dysferlinopathy/2379" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Qualitative or quantitative defects of dysferlin</ElementValue>
                <XRef ID="MONDO:0016145" DB="MONDO" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">Dysferlinopathy includes a spectrum of muscle disease characterized by two major phenotypes: Miyoshi muscular dystrophy (MMD) and limb-girdle muscular dystrophy type 2B (LGMD2B); and two minor phenotypes: asymptomatic hyperCKemia and distal myopathy with anterior tibial onset (DMAT). MMD (median age of onset 19 years) is characterized by muscle weakness and atrophy, most marked in the distal parts of the legs, especially the gastrocnemius and soleus muscles. Over a period of years, the weakness and atrophy spread to the thighs and gluteal muscles. The forearms may become mildly atrophic with decrease in grip strength; the small muscles of the hands are spared. LGMD2B is characterized by early weakness and atrophy of the pelvic and shoulder girdle muscles in adolescence or young adulthood, with slow progression. Other phenotypes in this spectrum are scapuloperoneal syndrome and congenital muscular dystrophy. Asymptomatic hyperCKemia is characterized by marked elevation of serum CK concentration only. DMAT is characterized by early and predominant distal muscle weakness, particularly of the muscles of the anterior compartment of the legs.</Attribute>
                <XRef ID="NBK1303" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="2003" />
                <XRef ID="2003" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301480</ID>
                <ID Source="BookShelf">NBK1303</ID>
              </Citation>
              <XRef ID="207073" DB="Orphanet" />
              <XRef ID="C2931687" DB="MedGen" />
              <XRef ID="MONDO:0016145" DB="MONDO" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="7073555" SubmissionDate="2023-02-03" DateLastUpdated="2023-11-11" DateCreated="2023-02-13">
        <ClinVarSubmissionID localKey="NM_003494.3_Deletion (Exons 51-55)|MedGen:C2931687" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003791366" DateUpdated="2023-11-11" DateCreated="2023-02-13" Type="SCV" Version="2" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-06-14">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">19594366</ID>
          </Citation>
          <Comment>This variant is a gross deletion of the genomic region encompassing exon(s) 51-55 of the DYSF gene, which includes the termination codon. This deletion extends beyond the assayed region for this gene and therefore may encompass additional genes. While this deletion is not anticipated to lead to nonsense mediated decay, it is expected to alter mRNA translation or result in a truncated protein product. This variant has not been reported in the literature in individuals affected with DYSF-related conditions. This variant disrupts a region of the DYSF protein in which other variant(s) (Deletion (Exon 55)) have been determined to be pathogenic (PMID: 19594366). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="DYSF" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000002.11:g.(?_71900503)_(71913622_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C2931687" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12699154</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7073555" TraitType="Disease" MappingType="XRef" MappingValue="C2931687" MappingRef="MedGen">
        <MedGen CUI="C2931687" Name="Qualitative or quantitative defects of dysferlin" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

